Theratechnologies shareholders approve acquisition by Future Pak affiliate

Published 12/09/2025, 16:30
Theratechnologies shareholders approve acquisition by Future Pak affiliate

MONTREAL - Theratechnologies Inc. (TSX:TH) (NASDAQ:THTX), a biopharmaceutical company with a market capitalization of $874 million and current trading price of $8.76, announced Friday that shareholders have approved the previously announced plan of arrangement with CB Biotechnology, LLC, an affiliate of Future Pak, LLC.

At the special meeting held Friday, the arrangement received approval from 97.44% of votes cast by shareholders present or represented by proxy. The plan also secured 97.43% approval from minority shareholders, meeting requirements under Multilateral Instrument 61-101. The strong shareholder support comes as Theratechnologies has demonstrated impressive momentum, with a 58.82% price return over the past six months, according to InvestingPro data.

The transaction still requires a final order from the Superior Court of Québec, with a hearing scheduled for September 16, 2025.

Theratechnologies is a specialty biopharmaceutical company that focuses on commercializing innovative therapies. Future Pak, founded in 1977 and headquartered in Wixom, Michigan, operates as a privately held contract manufacturer, packager and distributor of pharmaceutical and nutraceutical products.

The arrangement remains subject to customary closing conditions, including court approval and the completion of Future Pak’s anticipated debt financing related to the transaction.

The information in this article is based on a press release statement from Theratechnologies. Financial details of the transaction were not disclosed in the announcement.

In other recent news, Target Hospitality Corp reported its second-quarter earnings for 2025, surpassing revenue expectations with $62 million compared to the projected $59.43 million. However, the company’s earnings per share (EPS) came in at -$0.1223, slightly below the anticipated -$0.11. Additionally, Target Hospitality announced a significant move into the data center sector with a multi-year contract valued at $43 million, which will run through September 2027. This contract is expected to generate approximately $5 million in 2025. Stifel has responded to these developments by upgrading Target Hospitality’s stock rating from Hold to Buy, citing the company’s entry into the data center business as a key factor. Stifel also raised its price target for the company from $7.50 to $11.00. These recent developments reflect Target Hospitality’s strategic expansion and financial performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.